Polio Clinical Trials

3 recruiting

Polio Trials at a Glance

14 actively recruiting trials for polio are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Dhaka, Dublin, and Chicago. Lead sponsors running polio studies include PATH, Sinovac Biotech Co., Ltd, and University of Dublin, Trinity College.

Browse polio trials by phase

Treatments under study

About Polio Clinical Trials

Looking for clinical trials for Polio? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Polio trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Polio clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Myasthenia GravisAmyotrophic Lateral SclerosisNeuromuscular Diseases (NMD)+15 more
University of Missouri-Columbia50 enrolled1 locationNCT07478172
Recruiting
Phase 4

Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

Poliomyelitis
Sinovac Biotech Co., Ltd480 enrolled3 locationsNCT07457060
Recruiting
Phase 4

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

Poliomyelitis
Sinovac Biotech Co., Ltd180 enrolled3 locationsNCT07354269
Recruiting
Phase 2

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Poliomyelitis
PATH2,232 enrolled1 locationNCT05644184
Recruiting
Phase 2

Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

Poliomyelitis
PATH675 enrolled3 locationsNCT06895486
Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers

Poliomyelitis
CanSino Biologics Inc.480 enrolled1 locationNCT06577298
Recruiting
Phase 2Phase 3

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 1Phase 2

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Poliomyelitis
PATH2,400 enrolled2 locationsNCT06137664
Recruiting
Not Applicable

Nomad P-KAFO Study

Multiple SclerosisSpinal Cord InjuriesCerebrovascular Accident+3 more
Shirley Ryan AbilityLab36 enrolled1 locationNCT05644522
Recruiting
Not Applicable

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

DiphtheriaPolioPertussis+2 more
Jiangsu Province Centers for Disease Control and Prevention785 enrolled1 locationNCT06605755
Recruiting
Phase 3

Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd.1,557 enrolled9 locationsNCT06413121
Recruiting

Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease

Multiple SclerosisPrimary Lateral SclerosisMotor Neuron Disease / Amyotrophic Lateral Sclerosis+2 more
University of Dublin, Trinity College240 enrolled1 locationNCT06320444
Recruiting

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

Spinal Muscular AtrophyALS (Amyotrophic Lateral Sclerosis)Postpoliomyelitis Syndrome
University of Dublin, Trinity College400 enrolled1 locationNCT05663008
Recruiting

Evaluation of an Online Fatigue Self-management Group Intervention for Adults with Chronic Neurological Conditions

Fatigue secondary to Multiple Sclerosis, Parkinson's disease (PD), Cerebral Palsy, chronic fatigue syndrome and Post-polio syndrome
Curtin University135 enrolledACTRN12607000268448